Authors
Advertisement
Advertisement
Trending on HCPLive
1
Tezepelumab Meets Co-Primary End Points in Phase 3 CROSSING Trial in EoE
2
Mirikizumab Shows Early Efficacy in Pediatric UC in SHINE-2 Trial
3
Guselkumab Sustains Histologic Healing in Ulcerative Colitis Over 3 Years
4
Ratio of sTTR and NT-proBNP Change May Predict Treatment Results in ATTR-CM
5
